Cefotaxime sodium CAS No.64485-93-4 / Cat No.EBD17902
cefotaxim sodium salt
Cefotaxime sodium salt
Cefotaxime sodium
Claforan
sodium salt of 7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7 (Z)-(O-methyloxime), acetate (ester)
(6r-(6alpha,7beta(z)))-3-((acetyloxy)methyl)-(((2-amine-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylic acid monosodium salt
sodium (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2E)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]-8-oxo-, sodium salt, (6R,7R)- (1:1)
cefotaxim sodium
Claforan
CTX
[6R-[6alpha,7beta(z)]]-3-[(Acetyloxy)methyl]-[[(2-amine-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid monosodium salt
Cefotaxime sodium
Cefotaxime sodium
Claforan
Properties
-
Appearance:
White to pale yellow crystalline powder
-
Density:
1.8 g/cm3
-
Melting point:
162-163 °C
-
Storage temperature:
2-8°C
Safety Information
-
Symbol:
-
Signal words:
None
-
Hazard statements:
H317 May cause an allergic skin reaction.
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
-
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P284 Wear respiratory protection.
P304+P340 IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P342+P311 IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
NMR Spectrum
1H NMR
13C NMR
